SWP
CANC icon

Stratos Wealth Partners’s Tema Oncology ETF CANC Stock Holding History

Stratos Wealth Partners’s Portfolio CANC Stock Details CANC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$800K Buy
19,403
+3,112
+19% +$118K 0.01% 943
2026
Q1 		$598K Buy
+16,291
New +$593K 0.01% 992

Other funds holding CANC

Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $59.5B AUM 35.96% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
PIA
Perennial Investment Advisors Los Angeles, California $1.51B AUM 28.71% 1-Year Est. Return
OIM
Oder Investment Management Woodland Hills, California $149M AUM 20.29% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
WWM
WJ Wealth Management Glendale, Arizona $253M AUM 28.6% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
RF
Roxbury Financial Mount Arlington, New Jersey $126M AUM 23.88% 1-Year Est. Return

Stratos Wealth Partners's CANC Position: Q2 2026 in Review

Stratos Wealth Partners increased its Tema Oncology ETF (CANC) stake by 19% in Q2 2026, buying an estimated $118K and bringing the position to 19,403 shares worth $800K. The position accounts for 0.01% of the portfolio, ranked #943.

Stratos Wealth Partners first reported a position in CANC in Q1 2026 and has held it in 2 quarters since. 15 funds tracked by Wall St. Rank hold CANC as of Q2 2026.

  • Stratos Wealth Partners held 19,403 shares of Tema Oncology ETF worth $800K as of Q2 2026.
  • Stratos Wealth Partners bought 3,112 Tema Oncology ETF shares in Q2 2026, an estimated $118K.
  • Tema Oncology ETF made up 0.01% of Stratos Wealth Partners's portfolio in Q2 2026, its #943 holding.
  • Stratos Wealth Partners first reported a position in Tema Oncology ETF in Q1 2026 and has held it in 2 quarters since.
  • 15 funds tracked by Wall St. Rank held Tema Oncology ETF as of Q2 2026.

Based on Stratos Wealth Partners's 13F filing for Q2 2026, filed 11 Aug 2026.